Risk of Hospitalization in Patients with Alzheimer's Disease and Lewy Body Dementia: Time to and Length of Stay

被引:7
作者
Oesterhus, Ragnhild [1 ,2 ,3 ]
Dalen, Ingvild [4 ]
Bergland, Anne Katrine [1 ,7 ]
Aarsland, Dag [1 ,5 ]
Kjosavik, Svein R. [1 ,6 ]
机构
[1] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway
[2] Hosp Pharm Enterprise Western Norway, Bergen, Norway
[3] Univ Bergen, Dept Clin Med, Bergen, Norway
[4] Stavanger Univ Hosp, Dept Res, Stavanger, Norway
[5] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
[6] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway
[7] Univ Bergen, Dept Clin Sci, Bergen, Norway
关键词
Alzheimer's disease; dementia; hospitalization; length of stay; Lewy body dementia; patient admission; CLINICAL-DIAGNOSIS; BODIES; PEOPLE; FREQUENCY; ADMISSION;
D O I
10.3233/JAD-191141
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Patients with dementia are at high risk of being hospitalized, but there is little knowledge whether this applies to all forms of dementia. Objective: To investigate if there are differences in hospitalization between patients with Alzheimer's disease (AD) and Lewy body dementia (LBD), and further, to compare admission rate with the general age-matched population. Methods: Patients (age 75.7 +/- 7.4) recently diagnosed with mild form of AD (n = 110) or LBD (n = 91) were included from outpatient clinics. The participants were followed from time of diagnosis, for five years or until death. Study outcomes were time to first hospitalization after diagnosis, number of admissions, total number of hospital days, and length of stay. Age-standardized admission ratios were calculated. Time to first admission was analyzed using competing risks regression models, and differences in number of hospitalizations and hospital days were addressed using negative binomial regression models. Results: More than 77% of the patients were admitted, largely as unplanned hospitalizations. Patients with LBD had significantly shorter time until first hospitalization (median 1.28 years, 95% CI 0.93-1.67 versus AD: 2.32 years, 95% CI 1.74-3.31) and more days in hospital (median 13 days, IQR 4, 38), than patients with AD (7 days, IQR 0, 18). Conclusion: Our data indicates that patients with LBD have shorter time until first admission and higher admission rate than AD patients. This imposes a great burden on patients, their family, and the health care system. More knowledge about hospital admissions of people with dementia is needed. Future studies should investigate strategies to avoid potentially preventable admissions.
引用
收藏
页码:1221 / 1230
页数:10
相关论文
共 50 条
  • [41] Effects of Alzheimer's disease and Lewy body disease on subcortical atrophy
    Yoo, H. S.
    Lee, E. C.
    Chung, S. J.
    Lee, Y. H.
    Lee, S. G.
    Yun, M.
    Lee, P. H.
    Sohn, Y. H.
    Seong, J. -K.
    Ye, B. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (02) : 318 - 326
  • [42] Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy
    Chouliaras, Leonidas
    Thomas, Alan
    Malpetti, Maura
    Donaghy, Paul
    Kane, Joseph
    Mak, Elijah
    Savulich, George
    Prats-Sedano, Maria A.
    Heslegrave, Amanda J.
    Zetterberg, Henrik
    Su, Li
    Rowe, James Benedict
    O'Brien, John Tiernan
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, : 651 - 658
  • [43] Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer's disease patients
    Peraza, Luis R.
    Cromarty, Ruth
    Kobeleva, Xenia
    Firbank, Michael J.
    Killen, Alison
    Graziadio, Sara
    Thomas, Alan J.
    O'Brien, John T.
    Taylor, John-Paul
    SCIENTIFIC REPORTS, 2018, 8
  • [44] Attention Network Functioning in Patients with Dementia with Lewy Bodies and Alzheimer's Disease
    Fuentes, Luis J.
    Fernandez, Pedro J.
    Campoy, Guillermo
    Antequera, Martirio M.
    Garcia-Sevilla, Julia
    Antunez, Carmen
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2010, 29 (02) : 139 - 145
  • [45] Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis
    Meng, Yan-Hong
    Wang, Pan-Pan
    Song, Ya-Xue
    Wang, Jian-Hua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) : 1611 - 1624
  • [46] Contrasts Between Patients With Lewy Body Dementia Syndromes and APOE-ε3/ε3 Patients With Late-onset Alzheimer Disease Dementia
    Oliveira, Fabricio F.
    Machado, Fernando C.
    Sampaio, Gustavo
    Marin, Sheilla M. C.
    Chen, Elizabeth S.
    Smith, Marilia C.
    Bertolucci, Paulo H. F.
    NEUROLOGIST, 2015, 20 (02) : 35 - 41
  • [47] Differentiating Dementia with Lewy Bodies from Alzheimer?s Disease Using the Fall Risk Evaluation Questionnaire
    Tsujimoto, Masashi
    Suzuki, Keisuke
    Takeda, Akinori
    Saji, Naoki
    Sakurai, Takashi
    Washimi, Yukihiko
    INTERNAL MEDICINE, 2022, 61 (11) : 1687 - 1692
  • [48] Neuropsychiatric feature profiles of patients with Lewy body dementia
    de Oliveira, Fabricio Ferreira
    Machado, Fernando Chiodini
    Sampaio, Gustavo
    Correia Marin, Sheilla de Medeiros
    Naffah-Mazzacoratti, Maria da Graca
    Ferreira Bertolucci, Paulo Henrique
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 194
  • [49] Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer's Disease
    Zhu, Carolyn W.
    Gu, Yian
    Kociolek, Anton J.
    Fernandez, Kayri K.
    Cosentino, Stephanie
    Stern, Yaakov
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (02) : 457 - 466
  • [50] The Feasibility of Differentiating Lewy Body Dementia and Alzheimer's Disease by Deep Learning Using ECD SPECT Images
    Ni, Yu-Ching
    Tseng, Fan-Pin
    Pai, Ming-Chyi
    Hsiao, Ing-Tsung
    Lin, Kun-Ju
    Lin, Zhi-Kun
    Lin, Chia-Yu
    Chiu, Pai-Yi
    Hung, Guang-Uei
    Chang, Chiung-Chih
    Chang, Ya-Ting
    Chuang, Keh-Shih
    DIAGNOSTICS, 2021, 11 (11)